V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20224880 | 20085017 | 1.77 | 69.15 | Palliative (P) | 2019-07-16 | 2019-07-24 | Enzalutamide | 02 | N | ECF | 101069456 |
| 20224881 | 20085018 | 1.59 | 61.4 | Neo-adjuvant (N) | 2019-09-26 | 2019-10-01 | Enzalutamide | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100112695 |
| 20224888 | 20085019 | 0.75 | 72.3 | null | 2017-04-13 | 2017-04-13 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100446829 |
| 20224896 | 20085020 | 1.59 | 81 | Neo-adjuvant (N) | 2019-03-07 | 2019-03-12 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101860791 |
| 20224907 | 20085021 | 1.77 | 68 | Palliative (P) | 2016-03-25 | 2016-03-29 | Enzalutamide | 02 | N | CARBOPLATIN | 101276066 |
| 20224909 | 20085022 | 1.73 | 90 | null | 2016-03-09 | 2016-04-17 | Enzalutamide | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100323608 |
| 20224918 | 20085023 | 0 | 67.2 | Palliative (P) | 2020-01-30 | 2020-01-30 | Enzalutamide | 02 | N | CETUXIMAB | 101411468 |
| 20224930 | 20085024 | 1.76 | 94.5 | Palliative (P) | 2016-04-30 | 2016-05-25 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100295567 |
| 20224935 | 20085025 | 1.73 | 64.2 | Palliative (P) | 2016-07-03 | 2016-07-14 | Enzalutamide | N | N | CARBOPLATIN | 100659852 |
| 20224940 | 20085026 | 1.65 | null | null | 2017-07-23 | 2017-07-23 | Enzalutamide | 02 | null | TRASTUZUMAB | 101563740 |
| 20224942 | 20085027 | 1.53 | 59.5 | null | 2018-02-09 | 2018-02-13 | Capecitabine + Cisplatin + RT | N | null | CAPECITABINE + CISPLATIN + RT | 100586514 |
| 20224951 | 20085028 | 1.72 | 64.6 | Neo-adjuvant (N) | 2018-08-26 | 2018-09-25 | Enzalutamide | 02 | N | TRASTUZUMAB | 100316878 |
| 20224952 | 20085029 | 1.69 | 64.3 | Palliative (P) | 2020-01-02 | 2020-01-02 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100571834 |
| 20224955 | 20085030 | 1.56 | 67.5 | Palliative (P) | 2016-04-12 | 2016-04-12 | OCTREOTIDE | 02 | N | CETUXIMAB | 100129285 |
| 20224957 | 20085031 | 1.85 | 109.35 | null | 2019-04-08 | 2019-04-08 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100351642 |
| 20224959 | 20085032 | 1.6 | 56.5 | Palliative (P) | 2017-11-07 | 2017-11-07 | Enzalutamide | 2 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101029100 |
| 20224960 | 20085033 | 1.55 | 98 | 02 | 2019-07-07 | 2019-07-30 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101642878 |
| 20224963 | 20085034 | 1.75 | 69.6 | 03 | 2019-12-22 | 2019-12-22 | Enzalutamide | 02 | N | OCTREOTIDE | 100666003 |
| 20224964 | 20085035 | 0.87 | 90.3 | null | 2018-07-15 | 2018-07-23 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100605807 |
| 20224986 | 20085036 | 1.8 | 55.3 | Palliative (P) | 2017-04-26 | 2017-04-28 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100551438 |
| 20224988 | 20085037 | 1.86 | null | null | 2019-12-21 | 2019-12-29 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100284243 |
| 20224993 | 20085038 | 1.77 | 57.4 | Neo-adjuvant (N) | 2017-12-27 | 2018-01-05 | Capecitabine + Cisplatin + RT | 02 | N | SCALOP-2 TRIAL | 101421287 |
| 20224996 | 20085039 | 1.59 | 94 | null | 2016-02-11 | 2016-02-18 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN + RT | 100365035 |
| 20224998 | 20085040 | 1.47 | 91.5 | Neo-adjuvant (N) | 2017-05-14 | 2017-05-14 | Cisplatin | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100379250 |
| 20225005 | 20085041 | 1.87 | null | null | 2017-01-29 | 2017-01-29 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 101010503 |
| 20225007 | 20085042 | null | 76.9 | Neo-adjuvant (N) | 2021-04-05 | 2021-04-13 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100663055 |
| 20225022 | 20085043 | 1.55 | 109.6 | Palliative (P) | 2017-09-17 | 2017-09-19 | Enzalutamide | 2 | N | CETUXIMAB | 101322984 |
| 20225030 | 20085044 | 1.6 | 54.3 | Palliative (P) | 2012-06-10 | 2017-06-29 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 100779774 |
| 20225034 | 20085045 | 1.85 | 91.1 | Neo-adjuvant (N) | 2019-09-03 | 2019-09-10 | Capecitabine + Cisplatin + RT | 02 | null | CARBOPLATIN | 100226757 |
| 20225036 | 20085046 | 1.58 | 80 | Palliative (P) | 2017-06-02 | 2017-06-05 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101579458 |
| 20225038 | 20085047 | 1.7 | 71.9 | Neo-adjuvant (N) | 2016-05-13 | 2016-05-13 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100569967 |
| 20225047 | 20085048 | 1.7 | 67.5 | Palliative (P) | 2019-02-18 | 2019-03-09 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101276033 |
| 20225051 | 20085049 | 1.66 | 72.2 | Palliative (P) | 2020-08-09 | 2020-08-11 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101065015 |
| 20225062 | 20085050 | 1.53 | 82.2 | Palliative (P) | 2017-06-15 | 2017-06-29 | Enzalutamide | 02 | N | OCTREOTIDE | 100272663 |
| 20225070 | 20085051 | 1.65 | 81.9 | 03 | 2018-01-12 | 2018-03-25 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101155417 |
| 20225077 | 20085052 | 1.91 | 70.2 | Palliative (P) | 2016-12-22 | 2017-01-07 | Enzalutamide | N | N | ATEZOLIZUMAB + BEVACIZUMAB | 101043505 |
| 20225078 | 20085053 | 1.53 | 91 | Neo-adjuvant (N) | 2017-05-12 | 2017-05-13 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100890687 |
| 20225079 | 20085054 | 1.47 | 62.7 | null | 2017-02-10 | 2017-02-24 | Enzalutamide | N | null | CARBOPLATIN + GEMCITABINE | 101572369 |
| 20225081 | 20085055 | 1.67 | 53 | Palliative (P) | 2016-11-25 | 2016-12-14 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101042380 |
| 20225082 | 20085056 | 1.71 | 62.2 | Palliative (P) | 2020-07-14 | 2020-07-14 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100306348 |
| 20225086 | 20085057 | 1.66 | 69.7 | Palliative (P) | 2017-04-19 | 2017-04-21 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101692457 |
| 20225089 | 20085058 | 1.7 | 95.9 | Palliative (P) | 2019-09-06 | 2019-09-11 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | ECF | 101596235 |
| 20225094 | 20085059 | 1.81 | 74 | null | 2017-06-26 | 2017-07-02 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 100697439 |
| 20225096 | 20085060 | 0 | 0 | Palliative (P) | 2019-10-29 | 2019-12-02 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101814039 |
| 20225097 | 20085061 | 1.7 | 81.8 | Curative (C) | 2018-05-07 | 2018-06-03 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 101597125 |
| 20225102 | 20085062 | 1.5 | 109 | null | null | 2018-09-22 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 100736715 |
| 20225111 | 20085063 | null | 62.1 | Palliative (P) | 2018-09-25 | 2018-09-25 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CARBOPLATIN | 100817834 |
| 20225112 | 20085064 | 1.66 | 65.4 | Neo-adjuvant (N) | 2019-12-15 | 2020-01-03 | Enzalutamide | 02 | N | TRASTUZUMAB | 101205185 |
| 20225113 | 20085065 | 1.67 | 96.7 | Palliative (P) | 2019-04-27 | 2019-05-05 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101321902 |
| 20225118 | 20085066 | 1.74 | 100 | Palliative (P) | 2016-06-01 | 2016-08-10 | Enzalutamide | N | N | CISPLATIN | 100545998 |